Pharma Focus Asia

Shanghai Fosun Pharmaceutical Group unit receives GMP certificate

Tuesday, January 02, 2018

Shanghai Fosun Pharmaceutical Group Co Ltd Says its Jiangsu unit received goods manufacture practice (GMP) certificate from Jiangsu Food and Drug Administration.

Certificate issued tablets and hard capsules manufactured by the unit and the valid period is until Dec. 25, 2022.

magazine-slider-imageMFA + MMA 2024CPHI Chine || PMEC China 2024Asia Healthcare Week 2024Advance DoE WorkshopNitrosamine Advance Workshop 2024CPHI Korea 2024CHEMICAL INDONESIA 2024INALAB 2024 Thermo Scientific - DynaDrive and DynaSpinDigital Health Asia 2024Rehab Expo 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Pharmaceutical Manufacturing & Quality Conference2024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals ConferencePharma Quality Excellence Awards 20244th Annual Pharma GMP Quality Management 20243rd World ADC Asia 2024LogiPharma Asia 2024